- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
New device allows non-surgical blepharoplasty
Non-surgical blepharoplasty can provide surgeons with a minimally invasive approach to eyelid procedures.
Key Points
Marlton, NJ-Non-surgical blepharoplasty can provide surgeons with a minimally invasive approach to eyelid procedures.
Using a blepharoplasty device (EyeTight, LaserTight LLC), which is FDA cleared for lower lid blepharoplasty, the procedure is performed using local anesthesia and can be completed within 15 minutes. There is minimal downtime for the patient, and skin tightening continues for 6 to 8 weeks after the procedure.
The device uses 980-nm laser energy delivered through a customized 20-gauge endoprobe to vaporize fat cells. Other similar procedures using LaserTight devices can be performed on other parts of the body. Demand for such procedures is expected to increase.
